Prestige Consumer Healthcare Inc. — Form 8-K
Filed July 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 58/100
What the filing says
On July 1, 2026, Prestige Consumer Healthcare completed its acquisition of LaCorium Health for approximately $150 million in cash, funded from cash on hand and existing credit facilities. Concurrently, on July 6, 2026, the company priced a $400 million offering of 6.25% senior notes due 2034, with net proceeds to redeem the $400 million of 5.125% notes due January 2028 (closing expected ~July 15, 2026). LaCorium generates ~$40 million annual revenue and ~$12 million EBITDA (including synergies); approximately 75% of sales are from Australia where brands hold #1 lip care and #3 foot care market positions.
Why this rating
LaCorium acquisition (~5% of $3B market cap) is meaningful but modest. Debt refinancing at +100bps (5.125% to 6.25%) is ordinary cap structure mgmt. Modest revenue/EBITDA accretion expected post-integration.
See more from July 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.